Shanghai Xuerong Biotechnology Co., Ltd. (300511) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Xuerong Biotechnology Co., Ltd.

Why is Shanghai Xuerong Biotechnology Co., Ltd. ?

With a growth in Net Profit of 87.94%, the company declared Very Positive results in Sep 25

The company has declared positive results in Jan 70 after 2 consecutive negative quarters
OPERATING CASH FLOW(Y) Highest at CNY 450.87 MM
RAW MATERIAL COST(Y) Fallen by -563.51% (YoY)
DEBT-EQUITY RATIO (HY) Lowest at 86.56 %

With ROE of -44.88%, it has a risky valuation with a 2.83 Price to Book Value

Over the past year, while the stock has generated a return of 60.16%, its profits have fallen by -53.5%

Market Beating Performance

The stock has generated a return of 60.16% in the last 1 year, much higher than market (China Shanghai Composite) returns of 25.05%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Shanghai Xuerong Biotechnology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Other Agricultural Products should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai Xuerong Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shanghai Xuerong Biotechnology Co., Ltd.

43.07%

3.07

47.10%

China Shanghai Composite

24.7%

1.93

12.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.57%

EBIT Growth (5y)

-205.26%

EBIT to Interest (avg)

-2.40

Debt to EBITDA (avg)

44.06

Net Debt to Equity (avg)

1.44

Sales to Capital Employed (avg)

0.64

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.01%

ROE (avg)

1.48%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.83

EV to EBIT

-9.71

EV to EBITDA

-31.46

EV to Capital Employed

1.84

EV to Sales

2.76

PEG Ratio

Dividend Yield

ROCE (Latest)

-18.96%

ROE (Latest)

-44.88%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 450.87 MM

RAW MATERIAL COST(Y)

Fallen by -563.51% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 86.56 %

PRE-TAX PROFIT(Q)

Highest at CNY 41.82 MM

NET PROFIT(Q)

Highest at CNY 40.2 MM

EPS(Q)

Highest at CNY 0.06

-10What is not working for the Company

NET SALES(HY)

At CNY 874.11 MM has Grown at -14.8%

CASH AND EQV(HY)

Lowest at CNY 181.38 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.61 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 42.37 times

Here's what is working for Shanghai Xuerong Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY 41.82 MM has Grown at 129.05%

over average net sales of the previous four periods of CNY -143.98 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 40.2 MM has Grown at 127.95%

over average net sales of the previous four periods of CNY -143.85 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 450.87 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

Highest at CNY 41.82 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 40.2 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.06

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Lowest at 86.56 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -563.51% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Xuerong Biotechnology Co., Ltd.

Net Sales

At CNY 874.11 MM has Grown at -14.8%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Cash and Eqv

Lowest at CNY 181.38 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 4.61 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 42.37 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio